Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lucid Diagnostics Inc (LUCD)

Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire - Thu Nov 20, 7:15AM CST

Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire - Thu Nov 13, 7:00AM CST

Veris Health launched commercial phase of strategic partnership and relaunched development of implantable physiological monitor

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire - Wed Nov 12, 7:00AM CST

Processed 2,841 EsoGuard ® tests and recognized 3Q25 revenue of $1.2 million, ending quarter with over $47 million in proforma cash and extending runway through 2026 and well past upcoming reimbursement...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire - Wed Oct 29, 7:01AM CDT

Conference Call and Webcast at 8:30 AM Eastern Time

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire - Wed Oct 15, 7:01AM CDT

NEW YORK , Oct. 15, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors PR Newswire - Thu Sep 25, 7:01AM CDT

Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs PR Newswire - Tue Sep 16, 7:01AM CDT

Scelfo to strengthen and scale Lucid's market access infrastructure ahead of key upcoming reimbursement milestones—including Medicare coverage for EsoGuard—and to accelerate commercial coverage expansion...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Announces Closing of Public Offering of Common Stock PR Newswire - Thu Sep 11, 8:17AM CDT

NEW YORK , Sept. 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company,...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock PR Newswire - Wed Sep 10, 7:00AM CDT

NEW YORK , Sept. 10, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company,...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)
Lucid Diagnostics Announces Proposed Public Offering of Common Stock PR Newswire - Tue Sep 9, 3:01PM CDT

NEW YORK , Sept. 9, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company,...

LUCD : 1.0300 (-2.83%)
PAVM : 0.3290 (-3.52%)

Barchart Exclusives

Nvidia vs. Palantir: Which Stock Is the Better Long-Term AI Buy? Barchart - Sat Dec 6, 11:00AM CST
Nvidia builds the AI infrastructure of the future, while Palantir builds the intelligence that runs on it. Which is the better AI play? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot